Siegfried Oberndorfer
Siegfried Oberndorfer (24 June 1876 – 1944) was a German pathologist who is best known for his discovery of carcinoid tumors. His work significantly contributed to the field of oncology and the understanding of neuroendocrine tumors.
Early Life and Education[edit | edit source]
Siegfried Oberndorfer was born in Munich, Germany. He studied medicine at the Ludwig Maximilian University of Munich, where he developed an interest in pathology. After completing his medical degree, he worked under the guidance of prominent pathologists of his time.
Career[edit | edit source]
Oberndorfer began his career as an assistant at the Pathological Institute of Munich. His early work focused on the study of various types of tumors. In 1907, he published a seminal paper describing a new type of tumor, which he named "carcinoid" due to its resemblance to carcinoma but with a more benign behavior.
Discovery of Carcinoid Tumors[edit | edit source]
Oberndorfer's discovery of carcinoid tumors was a milestone in medical science. He observed that these tumors, although histologically similar to carcinomas, had a much slower growth rate and a better prognosis. This finding led to a new understanding of neuroendocrine tumors and their behavior.
Contributions to Medicine[edit | edit source]
Oberndorfer's work laid the foundation for the classification and treatment of neuroendocrine tumors. His research has had a lasting impact on the fields of pathology and oncology. He also contributed to the understanding of other types of tumors and their pathological characteristics.
Later Life and Legacy[edit | edit source]
During the Nazi regime, Oberndorfer, being of Jewish descent, faced persecution. Despite the challenges, he continued his research and teaching. He passed away in 1944, but his contributions to medical science continue to be recognized and respected.
Related Pages[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD